上海醫藥 (601607.SS)

18.02 -0.05 (-0.28%) 市場開市。 截至 02:25PM CST。

上海醫藥

Shanghai Pharmaceutical Building
No. 200 Taicang Road
Shanghai 200020
China
86 21 6373 0908
https://www.sphchina.com

版塊: Healthcare
行業: Medical Distribution
全職員工: 48,164

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Qiuhua Yang	Executive Chairman	無	無	1972
Mr. Bo Shen	President, CFO, Head of the Accounting Department & Executive Director	5.64M	無	1973
Mr. Yongzhong Li	VP & Executive Director	6.03M	無	1970
Mr. Ming Dong	Executive Director	無	無	1976
Mr. Tao Zhong	VP, Board Secretary & Joint Company Secretary	無	無	1972
Mr. Dongming Li	Vice President	無	無	1969
Ms. Shuai Shao	Vice President	無	無	1988
Dr. Shunjiang Yu	Chief Medical Officer	無	無	無
Ms. Pui Kiu Wong	Joint Company Secretary	無	無	無
Ying Ke	Director & General Manager of R&D Management Center	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 CNY。

描述

Shanghai Pharmaceuticals Holding Co., Ltd. engages research, development, manufacture, distribution, and retailing of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including digestive system, immune metabolism, motor neuron disease, endocrinology, cardiovascular, psychoneurotic, neoplasm, autoimmunity, systemic anti-infection, mental nerve, anti-tumor, oncology, respiratory system, nervous system, auto-immunity, hypertension, neuromyelitis, diabetes, anticholinesterase, polypeptide hormones uterine tonic, antihistamine, anti-inflammatory, anesthetic, immunomodulatory, antiviral, reflux esophagitis, analgesics, weight management, malignant peritoneal effusion, ulcerative colitis, myasthenia gravis, burn injury, anticoagulant, anti-epileptic, anticonvulsant, Alzheimer's, and inflammatory bowel diseases. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. The company was incorporated in 1994 and is headquartered in Shanghai, China.

公司管治

截至 2024年5月1日 止，上海醫藥 的 ISS 管治質素評分為 8。 Pillar 分數正在審核中：7；董事會：10；股東權利：9；現金賠償：2。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。